Mireille Mpoudi-Etame

Statistics

Publications

Citations

194

H-Index

Active since

2020

Affiliations

Institut de Recherche pour le Développement(Current)

Central Hospital of Yaoundé

Université de Montpellier

Université de Dschang

Inserm

Mireille Mpoudi-Etame is an author at Institut de Recherche pour le Développement specializing in medicine, emerging infectious diseases, and epidemiology.

ORCID

Top concepts

MedicineHivGlobal HealthClinical TrialsPharmacotherapyCovid-19EpidemiologyPublic HealthPathogen PrevalenceCovid-19 Epidemiology

Publications per year

2020–2023

Publications

Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open label, phase 3 non-inferiority trial in Cameroon

Alexandra Calmy, Tamara Tovar-Sanchez, Charles Kouanfack et al. · The Lancet HIV · 2020 · 155 citations

Open Label, Week 96, Treatment And Prevention +10

Rapid Increase of Community SARS-CoV-2 Seroprevalence during Second Wave of COVID-19, Yaoundé, Cameroon

Francis Atéba Ndongo, Emilande Guichet, Eric Mimbe et al. · Emerging infectious diseases · 2022 · 23 citations · Full text

Pathogen Prevalence, Virus Epidemiology, Emerging Infectious Diseases +13

Risks of metabolic syndrome in the ADVANCE and NAMSAL trials

Tamara Tovar-Sanchez, Mireille Mpoudi-Etame, Charles Kouanfack et al. · Frontiers in Reproductive Health · 2023 · 16 citations · Full text

1–3 of 3